Wordt geladen...
Clinical evidence of the efficacy of everolimus and its potential in the treatment of breast cancer
The PI3K/Akt/mTOR (phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin) pathway regulates several key cellular functions and its dysregulation creates an environment that promotes tumorigenesis as well as resistance to therapy. The mTOR inhibitor everolimus has emerged as a...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3929343/ https://ncbi.nlm.nih.gov/pubmed/24648755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S30131 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|